P339 Impact of a new rapid specialist sexual health result service on time from testing to treatment of Chlamydia trachomatis

Autor: M Clarke, L Harryman, J Steer, R Hopes, M Cox, R Gardiner, Helen Wheeler, Peter Muir, Patrick J Horner, Megan Crofts, S Moses, S Cochrane
Rok vydání: 2021
Předmět:
Zdroj: Poster presentations.
DOI: 10.1136/sextrans-2021-sti.389
Popis: Background Unity Sexual Health, Bristol UK, introduced a Panther (Hologic Inc) system in November 2018 at point-of-care. This rapid Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) nucleic acid amplification test (NAAT) provides results to patients within 4–48 working hours compared with 1–2 weeks previously. Patients are now only treated if CT NAAT-positive, symptomatic and unable to wait for results, or a sexual contact of CT/GC within the preceding 2 weeks. We hypothesised the new service would result in more rapid treatment of CT/GC infections. We evaluate the effect on time to CT treatment. Methods All new CT NAAT-positive cases attending over a 2-month period, 1 year before and 1 year after the introduction of the new service were evaluated (01/01/2018–28/02/2018 and 01/01/2020–28/02/2020). Dates of NAAT testing and treatment were obtained from electronic patient records. The one-sided Mann-Whitney U-test was used to compare time to treatment before and after service introduction. Results 134 CT-positive patients were diagnosed before and 116 were diagnosed after service introduction. Of these, 2 (1.5%) and 8 (6.9%) respectively were treated elsewhere and excluded. Average time to treatment decreased from 6.5 to 4.1 days (p = 0.09). When we excluded patients treated as contacts of CT (before NAAT result was available) the time to treatment decreased from 8.7 to 5.1 days (p Conclusions Introduction of a rapid STI service significantly reduced time from testing to treatment of CT. Availability of microscopy for symptomatic men allows immediate treatment of urethritis, a common presentation of CT in men. This probably explains why men were treated earlier than women. Earlier treatment is expected to reduce both asymptomatic CT transmission, and risk of CT complications, particularly in women.
Databáze: OpenAIRE